Photo Painless Minimally Invasive Treatment For Colorectal Cancer, Kill in Stage 2 Colorectal Cancer
Article Related to Stage 2 Colorectal Cancer :
Diagnose Colorectal Cancer or Colon Cancer – stage 2 colorectal cancer
Colorectal cancer, also known as CRC or colon cancer, is one of the leading cancers causing deaths in the U.S ., striking both men and women similarly. Transcending both prostate cancer and breast cancer in mortality rates, colon cancer is second to lung cancer in causing death. With roughly 150,000 new cases diagnosed per year and roughly 60,000 deaths a year, the miraculous actuality is that colon cancer is most preventable. The true is that when colon cancer is identified early, with medication, the 5-year survival rates is more than 90%. This is why colon cancer screening is crucial to prevent and quickly detect this deadly disease.
Colon Cancer Screening
The American Cancer Society recommends that both men and women is expected to adopt one of the following 5 colon cancer screening recommendations, even if they are only at average gamble for developing colon cancer.
* A yearly fecal occult blood assessment, likewise called FOBT, or a fecal immunochemical research, also announced FIT
* A flexible sigmoidoscopy experiment every 5 years
* A yearly fecal magical blood exam( FOBT) or fecal immunochemical test( FIT) including a flexible sigmoidoscopy every 5 years
* A double compare barium enema every 5 years
* A colonoscopy every 10 years
The most preferred option of all of these colon cancer screening recommendations is# 3: a yearly fecal occult blood evaluation( FOBT) or fecal immunochemical measure( FIT) including a adaptable sigmoidoscopy every 5 years. The American Cancer Society also recommends that all colon cancer screening assessments with positive results be immediately followed by a colonoscopy.
A New Home Colon Cancer Screening Kit
One of the most exciting new developments in colon cancer screening is the development of a brand-new residence assessment called Quidel’s QuickVue iFOB Test. This easy test is a type of fecal immunochemical test( FIT) that individual patients uses at home. In the privacy of dwelling, a patient obtains a sample, completes the contents of the kit, and mails a test to a specified specialist or laboratory for testing. This simple home colon cancer screening experiment identifies any blood in the sample, which indicates their own problems of gastrointestinal disorders like colon cancer.
Requiring simply one specimen, the Quidel QuickVue iFOB Test identifies human blood, or hemoglobin. Cases is not need to follow any dietary rules, however, there are a few rules considering medications. This distinguishes this home colon cancer screening assessment from guaiac located research with arduous restraints. The American Cancer Society recommends the Quidel QuickVue iFOB Test because it is patient friendly, resulting in more parties taking the test than with guaiac or FOBT experiments. When the colon cancer screening process is simple, the hope is that more patients will take the test.
Unfortunately, even with the advancements in colon cancer screening, fewer than 50% of people over the age of 50 make the test on the recommendations of basis. Countless people over this age have never even made a colon cancer screening research. Education shall respond. If people knew that it could make 10 times for cancerous cells to take over, they would realize that early identification through a colon cancer screening is an easy and painless behavior to save “peoples lives”